FDA approves second anti-amyloid antibody for Alzheimer disease
Year: 2023
Type: article
Source: Nature Reviews Drug Discovery
Author: Asher Mullard
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4313893453
